GW&K Investment Management LLC boosted its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 1.9% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 243,407 shares of the healthcare conglomerate’s stock after buying an additional 4,581 shares during the period. UnitedHealth Group makes up approximately 0.7% of GW&K Investment Management LLC’s investment portfolio, making the stock its 27th largest position. GW&K Investment Management LLC’s holdings in UnitedHealth Group were worth $52,897,000 at the end of the most recent reporting period.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.
A number of other institutional investors have also recently made changes to their positions in the business. Lincoln Capital Corp grew its stake in UnitedHealth Group by 2.1% during the third quarter. Lincoln Capital Corp now owns 8,300 shares of the healthcare conglomerate’s stock worth $1,804,000 after buying an additional 170 shares in the last quarter. Benjamin F. Edwards & Company Inc. boosted its stake in shares of UnitedHealth Group by 140.6% in the 3rd quarter. Benjamin F. Edwards & Company Inc. now owns 14,779 shares of the healthcare conglomerate’s stock valued at $3,212,000 after purchasing an additional 8,636 shares in the last quarter. Taylor Hoffman Wealth Management boosted its stake in shares of UnitedHealth Group by 146.4% in the 3rd quarter. Taylor Hoffman Wealth Management now owns 3,287 shares of the healthcare conglomerate’s stock valued at $714,000 after purchasing an additional 1,953 shares in the last quarter. BigSur Wealth Management LLC boosted its stake in shares of UnitedHealth Group by 111.1% in the 3rd quarter. BigSur Wealth Management LLC now owns 10,450 shares of the healthcare conglomerate’s stock valued at $2,271,000 after purchasing an additional 5,500 shares in the last quarter. Finally, Principle Wealth Partners LLC boosted its stake in shares of UnitedHealth Group by 16.1% in the 3rd quarter. Principle Wealth Partners LLC now owns 3,741 shares of the healthcare conglomerate’s stock valued at $813,000 after purchasing an additional 519 shares in the last quarter. Hedge funds and other institutional investors own 85.66% of the company’s stock.
NYSE:UNH traded up $0.51 during mid-day trading on Friday, hitting $256.97. 2,161,274 shares of the company’s stock were exchanged, compared to its average volume of 4,544,972. The company has a 50 day simple moving average of $234.76 and a 200-day simple moving average of $241.05. The company has a current ratio of 0.70, a quick ratio of 0.67 and a debt-to-equity ratio of 0.67. UnitedHealth Group Inc has a fifty-two week low of $208.07 and a fifty-two week high of $287.94. The firm has a market capitalization of $237.20 billion, a P/E ratio of 19.95, a PEG ratio of 1.33 and a beta of 0.61.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $3.88 EPS for the quarter, topping the consensus estimate of $3.75 by $0.13. UnitedHealth Group had a net margin of 5.57% and a return on equity of 25.30%. The business had revenue of $60.35 billion for the quarter, compared to the consensus estimate of $59.84 billion. During the same period last year, the company earned $3.41 EPS. The firm’s revenue was up 6.7% compared to the same quarter last year. As a group, analysts expect that UnitedHealth Group Inc will post 14.96 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a dividend of $1.08 per share. This represents a $4.32 annualized dividend and a yield of 1.68%. UnitedHealth Group’s dividend payout ratio is presently 33.54%.
In other UnitedHealth Group news, CAO Thomas E. Roos sold 1,177 shares of the firm’s stock in a transaction that occurred on Thursday, November 7th. The shares were sold at an average price of $255.04, for a total transaction of $300,182.08. Following the completion of the transaction, the chief accounting officer now owns 21,687 shares in the company, valued at approximately $5,531,052.48. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Timothy Patrick Flynn purchased 2,000 shares of the stock in a transaction on Wednesday, August 28th. The shares were purchased at an average price of $227.55 per share, with a total value of $455,100.00. Following the acquisition, the director now owns 5,524 shares in the company, valued at approximately $1,256,986.20. The disclosure for this purchase can be found here. Over the last quarter, insiders have sold 33,177 shares of company stock worth $7,842,582. 0.87% of the stock is owned by corporate insiders.
A number of equities research analysts have recently weighed in on the stock. Raymond James raised their price target on shares of UnitedHealth Group from $265.00 to $300.00 and gave the company a “buy” rating in a research note on Friday, July 19th. Morgan Stanley reduced their price target on shares of UnitedHealth Group from $298.00 to $294.00 and set an “overweight” rating on the stock in a research note on Thursday, September 26th. UBS Group reduced their price target on shares of UnitedHealth Group from $281.00 to $257.00 and set a “neutral” rating on the stock in a research note on Thursday, October 17th. Oppenheimer set a $312.00 price target on shares of UnitedHealth Group and gave the company a “buy” rating in a research note on Friday, July 19th. Finally, Credit Suisse Group set a $293.00 price target on shares of UnitedHealth Group and gave the company a “buy” rating in a research note on Thursday, August 29th. Five research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $283.84.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Read More: Why is total return important?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).